Stephen E Weis1, Isabel Vecino, Janice M Pogoda, Joseph S Susa. 1. Dermatology Division, Department of Internal Medicine, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas 76107, USA. weistephen@me.com
Abstract
BACKGROUND:High-grade anal intraepithelial neoplasia, the putative anal carcinoma precursor, is more common in HIV-infected persons. The ideal treatment for these lesions has not been established. OBJECTIVE: The aim of this study was to evaluate the effectiveness of infrared coagulation treatment for high-grade anal intraepithelial neoplasia. DESIGN: This is a prospective cohort study. Patients with high-grade anal intraepithelial neoplasia either receivedinfrared coagulation treatment or voluntarily did not receive treatment and were reevaluated at a subsequent time point. SETTING: This investigation was performed at a Ryan White-funded clinic located in the United States. PATIENTS: HIV-infected men and women with biopsy-confirmed high-grade anal intraepithelial neoplasia were included. MAIN OUTCOME MEASURES: The primary outcome measured was the histology collected by high-resolution anoscopy-directed biopsy. RESULTS: The study included 124 patients. Of 42 patients who either delayed treatment or were not treated, 37 (88%; 95% CI = 74%-96%) still had high-grade anal intraepithelial neoplasia on reevaluation and 2 (5%; 95%CI = 1%-16%) had squamous-cell carcinoma. Of 98 patients who receivedinfrared coagulation treatment, 73 (74%; 95% CI = 65%-83%) patients had no evidence of high-grade anal intraepithelial neoplasia on their first posttreatment evaluation, and none had progressed to squamous-cell carcinoma (p < 0.0001 in comparison with untreated). Upon completing all initial and, if necessary, follow-up treatment, 85 (87%; 95% CI = 78%-93%) patients treated by infrared coagulation had no evidence of high-grade anal intraepithelial neoplasia and none had progressed to squamous-cell carcinoma. LIMITATIONS: The study population may not be representative of the general population, the study environment was uncontrolled, and patients were not randomly assigned to treatment. CONCLUSIONS: Infrared coagulation is an effective treatment for high-grade anal intraepithelial neoplasia.
RCT Entities:
BACKGROUND: High-grade anal intraepithelial neoplasia, the putative anal carcinoma precursor, is more common in HIV-infectedpersons. The ideal treatment for these lesions has not been established. OBJECTIVE: The aim of this study was to evaluate the effectiveness of infrared coagulation treatment for high-grade anal intraepithelial neoplasia. DESIGN: This is a prospective cohort study. Patients with high-grade anal intraepithelial neoplasia either received infrared coagulation treatment or voluntarily did not receive treatment and were reevaluated at a subsequent time point. SETTING: This investigation was performed at a Ryan White-funded clinic located in the United States. PATIENTS: HIV-infectedmen and women with biopsy-confirmed high-grade anal intraepithelial neoplasia were included. MAIN OUTCOME MEASURES: The primary outcome measured was the histology collected by high-resolution anoscopy-directed biopsy. RESULTS: The study included 124 patients. Of 42 patients who either delayed treatment or were not treated, 37 (88%; 95% CI = 74%-96%) still had high-grade anal intraepithelial neoplasia on reevaluation and 2 (5%; 95%CI = 1%-16%) had squamous-cell carcinoma. Of 98 patients who received infrared coagulation treatment, 73 (74%; 95% CI = 65%-83%) patients had no evidence of high-grade anal intraepithelial neoplasia on their first posttreatment evaluation, and none had progressed to squamous-cell carcinoma (p < 0.0001 in comparison with untreated). Upon completing all initial and, if necessary, follow-up treatment, 85 (87%; 95% CI = 78%-93%) patients treated by infrared coagulation had no evidence of high-grade anal intraepithelial neoplasia and none had progressed to squamous-cell carcinoma. LIMITATIONS: The study population may not be representative of the general population, the study environment was uncontrolled, and patients were not randomly assigned to treatment. CONCLUSIONS: Infrared coagulation is an effective treatment for high-grade anal intraepithelial neoplasia.
Authors: Stephen E Goldstone; Shelly Y Lensing; Elizabeth A Stier; Teresa Darragh; Jeannette Y Lee; Annemieke van Zante; Naomi Jay; J Michael Berry-Lawhorn; Ross D Cranston; Ronald Mitsuyasu; David Aboulafia; Joel M Palefsky; Timothy Wilkin Journal: Clin Infect Dis Date: 2019-03-19 Impact factor: 9.079
Authors: Robert N Goldstone; Shirin R Hasan; Steven Drury; Teresa M Darragh; Annemieke van Zante; Stephen E Goldstone Journal: Int J Colorectal Dis Date: 2016-10-21 Impact factor: 2.571
Authors: J Corral; D Parés; F García-Cuyás; B Revollo; S Videla; A Chamorro; M Piñol; B Clotet; G Sirera Journal: Tech Coloproctol Date: 2019-07-23 Impact factor: 3.781
Authors: G A Binda; G Gagliardi; I Dal Conte; M Verra; P Cassoni; E Cavazzoni; E Stocco; S Delmonte; P De Nardi; L Sticchi; M Mistrangelo Journal: Tech Coloproctol Date: 2019-06-26 Impact factor: 3.781
Authors: E Kaufman; C de Castro; T Williamson; B Lessard; M Munoz; M H Mayrand; A N Burchell; M B Klein; L Charest; M Auger; V Marcus; F Coutlée; A de Pokomandy Journal: Curr Oncol Date: 2020-02-01 Impact factor: 3.677
Authors: William C Mathews; Wollelaw Agmas; Edward R Cachay; Bard C Cosman; Christopher Jackson Journal: PLoS One Date: 2014-08-07 Impact factor: 3.240